Press release
Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends
Neoantigen Targeted Therapies Market Share
The neoantigen targeted therapies market has been growing significantly and is projected to continue this trend.
•2024 Market Size: $3.4 billion
•2025 Market Size: $4.72 billion (38.7% CAGR)
•2029 Market Size: $16.01 billion (35.7% CAGR)
These developments owe much to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, molecular profiling advancements among others.
What Is Driving The Growth In The Neoantigen Targeted Therapies Market?
The striking rise in cancer cases worldwide is a major catalyst propelling the growth of the neoantigen targeted therapies market. The incidence of cancer refers to the number of new cancer cases reported within a certain period in a specific population. Neoantigen-targeted therapies are often combined with other treatments to tackle different cancer types. Records from the American Cancer Society shows that in 2022, there were about 1.9 million new cancer cases in the United States, a considerably higher figure compared to previous years. More so, it was estimated that 609,360 deaths in the US were as a result of cancer. Thus, the escalating incidence of cancer cases is indeed a primary driver for the neoantigen targeted therapies market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
Who Are the Key Players Driving Neoantigen Targeted Therapies Market Growth?
•F. Hoffmann-La Roche AG
•Merck and Co. Inc.
•Bristol Myers Squibb Company
•Eli Lilly and Company
•Kite Pharma Inc., Gilead Sciences Inc.
•Amgen Inc.
•Moderna Inc.
•BioNTech SE
•Bavarian Nordic Inc.
•Advaxis Inc.
•Immatics NV
•Precision Biologics Inc.
•Iovance Biotherapeutics Inc.
•Agenus Inc.
•Achilles Therapeutics Plc
•Medigene AG
•Gritstone Bio Inc.
•SQZ Biotechnologies Company
•Aduro BioTech Inc.
•Inovio Pharmaceuticals Inc.
•Gradalis Inc.
•EpiVax Inc.
•ISA Pharmaceuticals BV
•Vaxon Biotech SA
•Ziopharm Oncology
•Genocea Biosciences Inc.
•Cellular Biomedicine Group Inc.
•Immunovaccine Inc.
What Are The Key Trends In The Neoantigen Targeted Therapies Market?
•Neoantigen resistance management
•Neoantigen-primed adoptive cell therapies
•Neoantigen-based combinatorial therapies
•Integration of real-world data
•Enhanced predictive models
What Are The Segments Of The Global Neoantigen Targeted Therapies Market?
•Type: Monotherapy, Combination Therapy
•Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
•Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
•Route Of Administration: Intradermal, Intravenous, Subcutaneous
•Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Which Region Leads The Neoantigen Targeted Therapies Market?
North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
What Is Covered In The Neoantigen Targeted Therapies Market Global Market Report?
- Market Size Analysis: Analyze the Neoantigen Targeted Therapies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neoantigen Targeted Therapies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neoantigen Targeted Therapies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neoantigen Targeted Therapies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11944&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends here
News-ID: 3834360 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Neoantigen
Neoantigen Cancer Vaccine Market Size, Share & CAGR 69.43% to 2034
What is driving the explosive growth of the neoantigen cancer vaccine market?
The neoantigen cancer vaccine market is seeing one of the most rapid growth trajectories in modern oncology. With a market size of USD 116.74 million in 2024, it is projected to reach USD 22,757.41 million by 2034, growing at a CAGR of 69.43%. This unprecedented growth is being fueled by advancements in genomic technologies, the success of mRNA platforms…
Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Neoantigen Targeted Therapies Industry Market Size Be by 2025?
There has been a notable expansion in the market size of neoantigen targeted therapies in the last few years. This market is projected to grow from $3.4 billion in 2024 to $4.72 billion in 2025, experiencing a…
Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.
Request for Free Sample…
Neoantigen Peptide Manufacturing Market Research Report 2023 - InsightAce Analyt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during…
Neoantigen Cancer Vaccine Market Will Touch USD 1,322.8 Million by 2030
According to P&S Intelligence, the global neoantigen cancer vaccine market was valued at USD 24.4 million in 2022, and it will advance at a mammoth 67.6% compound annual growth rate, to touch USD 1,322.8 million, by 2030.
The key factor boosting the advancement of the industry include the mounting incidence of cancer and surging research activities all over the world. Moreover, because of the growing importance of personalized treatments of…
Neoantigen Targeted Therapies Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Neoantigen Targeted Therapies Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Neoantigen Targeted Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neoantigen Targeted Therapies with respect…
